Statin drugs (drug interactions)
Statin drugs are medications used primarily to improve cholesterol levels and reduce the risk of cardiovascular disease. However, they can interact with various substances, leading to potentially harmful effects. Certain herbal supplements, such as chaparral, comfrey, and coltsfoot, are known for their liver toxicity and may amplify the risk of liver damage when combined with statins. Other herbs, like St. John's wort and Chinese skullcap, can lower the effectiveness of statins by reducing their blood levels. Grapefruit juice is particularly notable for its ability to inhibit the metabolism of statins, resulting in elevated drug levels and increased side effects.
Additionally, while high doses of vitamin B3 (niacin) can enhance cholesterol management when combined with statins, this combination carries a risk of rhabdomyolysis, a serious muscle condition. Pomegranate juice has also been linked to increased risks when taken with rosuvastatin. On the positive side, Coenzyme Q10 (CoQ10) supplementation may help counteract some side effects associated with statins, although research findings have been mixed. Moreover, combining fish oil with statins has shown potential benefits for improving lipid profiles. Overall, individuals taking statins should consult healthcare professionals about potential drug interactions, including with common herbs and supplements.
Statin drugs (drug interactions)
- DEFINITION: Medications used to improve cholesterol profile.
- INTERACTIONS: Chaparral, Chinese skullcap, coenzyme Q10, coltsfoot, comfrey, fish oil, goldenseal, grapefruit juice, kava, pomegranate, prescription medications, red yeast rice, St. John’s wort, vitamin B3
- DRUGS IN THIS FAMILY: Atorvastatin calcium (Lipitor), fluvastatin (Lescol), lovastatin (Mevacor), pravastatin (Pravachol), simvastatin (Zocor), rosuvastatin (Crestor)
Chaparral, Comfrey, and Coltsfoot
Effect: Possible Harmful Interaction
The herb chaparral (Larrea tridentata or L. mexicana) has been promoted for use in arthritis, cancer, and various other conditions, but insufficient evidence supports its effectiveness. There are, however, concerns about its apparent liver toxicity. Several cases of chaparral-induced liver damage have been reported, some of them severe enough to require liver transplantation. Based on these reports, combining chaparral with other agents that are harmful to the liver, such as statin drugs, may amplify the risk of potential liver problems. Other herbs that are toxic to the liver include comfrey (Symphytum officinale) and coltsfoot (Tussilago farfara). Goldenseal and kava, which affect liver enzymes, should also be avoided.
Chinese Skullcap
Effect: Possible Harmful Interaction
The herb Chinese skullcap (Scutellaria baicalensis) contains baicalin as one of its presumed major active ingredients. One study found evidence that baicalin consumption might lower blood levels of statin drugs.
St. John’s Wort
Effect: Possible Harmful Interaction
The herb St. John’s wort, used to treat depression, may decrease blood levels of various drugs in the statin family, including simvastatin, lovastatin, and atorvastatin (but possibly not pravastatin). One study documented that when people taking atorvastatin for high cholesterol additionally took St. John’s wort, cholesterol levels promptly rose.
Grapefruit Juice
Effect: Possible Harmful Interaction
Grapefruit juice impairs the body’s normal breakdown of several drugs, including statins, allowing them to build up to potentially excessive levels in the blood. One study indicates that this effect can last three days or more following the last glass of grapefruit juice.
Because grapefruit juice can increase the risk of serious drug side effects, persons taking interacting statins should avoid grapefruit juice altogether. Grapefruit juice may not affect fluvastatin or pravastatin because these drugs are broken down differently than other statins.
Vitamin B3
Effect: Possible Benefits and Risks
Niacin (nicotinic acid) is vitamin B3. Niacin is effective in lowering cholesterol levels in high doses (often 1,500 milligrams [mg] daily or more). Its other form, niacinamide (nicotinamide), does not affect cholesterol.
Combining high-dose niacin with statin drugs further improves cholesterol profile by raising high-density lipoprotein (HDL or good) cholesterol. However, there are real concerns that this combination therapy could cause a potentially fatal condition of muscle breakdown called rhabdomyolysis.
However, a growing body of evidence suggests that the risk is relatively slight in persons with healthy kidneys. Furthermore, even much lower doses of niacin than the usual dose given to improve cholesterol levels (100 mg versus 1,000 mg or more) may provide a similar benefit. At this dose, the risk of rhabdomyolysis should be decreased. Nonetheless, it is not safe to try this combination except under close physician supervision.
Pomegranate
Effect: Possible Harmful Interaction
One case report suggests that pomegranate juice consumption might increase the risk of rhabdomyolysis when rosuvastatin (Crestor) is used.
Red Yeast Rice
Effect: Possible Harmful Interaction
Red yeast rice is an herbal cholesterol-lowering therapy. It contains a mixture of statins, the primary of which is lovastatin, which most closely resembles the prescription drug Mevacor. Because of this similarity, the two should not be combined without medical supervision.
Coenzyme Q10 (CoQ10)
Effect: Supplementation Possibly Helpful
CoQ10 is a vitamin-like substance that is fundamental to the body’s energy production and appears essential for normal heart function. Statin drugs inhibit the enzyme necessary for the body’s synthesis of both cholesterol and CoQ10 and, as an inevitable part of their mechanism of action, reduce CoQ10 levels in the body. Because these drugs are used to protect the heart, and because CoQ10 deficiency could in theory impair heart function, it has been suggested that this side effect may work against the intended purpose of taking statins. Furthermore, one might naturally hypothesize that this induced CoQ10 deficiency could cause some of the side effects of statins.
Taking CoQ10 supplements prevents the lowering of CoQ10 levels caused by statin drugs and accomplishes this without interfering with their therapeutic effects. However, studies designed to determine whether the use of CoQ10 supplements actually offers any benefit to people taking statins have returned inconsistent results at best. For example, a relatively large double-blind, placebo-controlled trial of forty-four people failed to find that the use of CoQ10 at a dose of 200 mg daily reduced the side effects of simvastatin.
Fish Oil
Effect: Supplementation Probably Helpful
Double-blind, placebo-controlled studies suggest that combining fish oil (or its constituent docosahexaenoic acid, or DHA) with statin drugs may improve lipid profile.
Other Interactions
Natural products and herbs are not the only substances that can cause dangerous interactions when taken with statin drugs. There are several traditional medications that should be avoided as well. Antifungal medications can increase the levels of statins in the blood and increase side effects such as muscle pain. Specific antibiotics and medications for Human Immunodeficiency Virus (HIV) can have similar effects. Patients are also advised to avoid other cholesterol-lowering medications and specific heart rhythm medications when taking statin drugs.
Bibliography
Andrén, L., A. Andreasson, and R. Eggertsen. "Interaction Between a Commercially Available St. John’s Wort Product (Movina) and Atorvastatin in Patients with Hypercholesterolemia." European Journal of Clinical Pharmacology, vol. 63, 2007, pp. 913-916.
"Grapefruit Juice and Some Drugs Don't Mix." FDA, 1 July 2021, www.fda.gov/consumers/consumer-updates/grapefruit-juice-and-some-drugs-dont-mix. Accessed 8 Oct. 2024.
Koda-Kimble, Mary Anne, et al., editors. Applied Therapeutics: The Clinical Use of Drugs. 9th ed., Lippincott Williams & Wilkins, 2008.
"Managing Interactions Between Macrolides and Statins." Specialist Pharmacy Service, 12 July 2024, www.sps.nhs.uk/articles/managing-interactions-between-macrolides-and-statins. Accessed 8 Oct. 2024.
Marcoff, L., and P. D. Thompson. "The Role of Coenzyme Q10 in Statin-Associated Myopathy." Journal of the American College of Cardiology, vol. 49, 2007, pp. 2231-2237.
Shpati, Kleva, Gentian Stroni, Erina Hilaj, Aurora Napuce, and Genta Rexha. "Monitoring Adverse Drug Reactions and Incidence of Potential Statin-Drug Interactions." Journal of Pharmacology and Pharmacotherapeutics, vol. 12, no. 4, 1 Dec. 2021, DOI: 10.4103/jpp.jpp‗79‗21. Accessed 21 Dec. 2022.
Sorokin, A. V., et al. "Rhabdomyolysis Associated with Pomegranate Juice Consumption." American Journal of Cardiology, vol. 98, 2006, pp. 705-706.
"Statins." Cleveland Clinic, 12 Mar. 2024, my.clevelandclinic.org/health/treatments/22282-statins. Accessed 8 Oct. 2024.
Strey, C. H., et al. "Endothelium-ameliorating Effects of Statin Therapy and Coenzyme Q(10) Reductions in Chronic Heart Failure." Atherosclerosis, vol. 179, 2005, pp. 201-206.
Young, J. M., et al. "Effect of Coenzyme Q(10) Supplementation on Simvastatin-Induced Myalgia." American Journal of Cardiology, vol. 100, 2007, pp. 1400-1403.